Radiotherapy (RT) Dose-intensification (DI) Using Intensity-modulated RT (IMRT) versus Standard-dose (SD) RT with Temozolomide (TMZ) in Newly Diagnosed Glioblastoma (GBM): Preliminary Results of NRG Oncology BN001

Authors :: Ozer Algan
Vinai Gondi
Kenneth Aldape
Ashok Srinivasan
Jean-Paul Bahary
C.L. Rogers
Antonio Omuro
Wenyin Shi
Minesh P. Mehta
J. Mcdonough
Stephanie L. Pugh
Thomas L. Chenevert
Michael D. Chan
Mark R. Gilbert
John H. Suh
Christina Tsien
Lucien A. Nedzi
Source :: International Journal of Radiation Oncology*Biology*Physics. 108:S22-S23
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Radiation
Temozolomide
business.industry
medicine.medical_treatment
Newly diagnosed
medicine.disease
Radiation therapy
Intensity Modulated RT
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Dose intensification
business
medicine.drug
Glioblastoma

Full Text Access

Tools